Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

LMDX

LumiraDx (LMDX)

LumiraDx Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LMDX
DateTimeSourceHeadlineSymbolCompany
06/01/202409:45GlobeNewswire Inc.LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9thNASDAQ:LMDXLumiraDx Ltd
30/12/202309:07Dow Jones NewsLumiraDx Agrees to Sell Point-of-Care Tech Platform to RocheNASDAQ:LMDXLumiraDx Ltd
30/12/202308:15GlobeNewswire Inc.LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to RocheNASDAQ:LMDXLumiraDx Ltd
28/10/202307:45GlobeNewswire Inc.LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to AppealNASDAQ:LMDXLumiraDx Ltd
21/10/202309:34GlobeNewswire Inc.LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening HubNASDAQ:LMDXLumiraDx Ltd
24/08/202321:45GlobeNewswire Inc.LumiraDx Reports Second Quarter 2023 ResultsNASDAQ:LMDXLumiraDx Ltd
17/08/202306:30GlobeNewswire Inc.LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24NASDAQ:LMDXLumiraDx Ltd
31/07/202320:00GlobeNewswire Inc.LumiraDx’s Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and TestsNASDAQ:LMDXLumiraDx Ltd
01/07/202305:26Dow Jones NewsLumiraDx Submits Dual FDA Medical Device Application for Covid-19 TestNASDAQ:LMDXLumiraDx Ltd
01/07/202304:30GlobeNewswire Inc.LumiraDx Submits First 510(k) Application to the FDA for COVID Ultra TestNASDAQ:LMDXLumiraDx Ltd
21/06/202306:15GlobeNewswire Inc.LumiraDx Receives UK CTDA Approval for COVID Ultra and COVID & RSV TestsNASDAQ:LMDXLumiraDx Ltd
16/05/202321:45GlobeNewswire Inc.LumiraDx Reports First Quarter 2023 ResultsNASDAQ:LMDXLumiraDx Ltd
10/05/202306:15GlobeNewswire Inc.LumiraDx to Announce First Quarter Financial Results and Host Quarterly Conference Call on May 16NASDAQ:LMDXLumiraDx Ltd
25/04/202306:21GlobeNewswire Inc.LumiraDx Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:LMDXLumiraDx Ltd
06/04/202323:20GlobeNewswire Inc.LumiraDx Announces Strategic Refocus and Cost Restructuring ProgramNASDAQ:LMDXLumiraDx Ltd
21/03/202322:26GlobeNewswire Inc.LumiraDx Reports Fourth Quarter and Full Year 2022 ResultsNASDAQ:LMDXLumiraDx Ltd
14/03/202323:03GlobeNewswire Inc.LumiraDx to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Quarterly Conference Call on March 21NASDAQ:LMDXLumiraDx Ltd
04/03/202301:00GlobeNewswire Inc.LumiraDx to Present at Raymond James Institutional Investors ConferenceNASDAQ:LMDXLumiraDx Ltd
21/02/202303:00GlobeNewswire Inc.LumiraDx Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:LMDXLumiraDx Ltd
07/02/202300:59Dow Jones NewsLumiraDx Gets FDA Emergency Authorization for Dual Flu-COVID TestNASDAQ:LMDXLumiraDx Ltd
07/02/202300:00GlobeNewswire Inc.LumiraDx Receives FDA Emergency Use Authorization and UK CTDA Approval for its Fast Lab Solutions Multiplex COVID and Influenza Molecular AssayNASDAQ:LMDXLumiraDx Ltd
01/02/202308:30GlobeNewswire Inc.LumiraDx Announces Commercial Shipment of its Point of Care NT-proBNP Test in Europe, Supporting Heart Health Checks in UKNASDAQ:LMDXLumiraDx Ltd
01/02/202308:15GlobeNewswire Inc.LumiraDx Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price DeficiencyNASDAQ:LMDXLumiraDx Ltd
14/12/202219:19GlobeNewswire Inc.LumiraDx Announces New Investment for Ongoing Development of its Point of Care Molecular Tuberculosis TestNASDAQ:LMDXLumiraDx Ltd
08/12/202219:01GlobeNewswire Inc.Latest Clinicians’ U.S. Survey Identifies Point of Care Testing (POCT) as a Way to Address Healthcare Bandwidth Pressures and Anticipates Future Growth of POCT in Community Testing CentersNASDAQ:LMDXLumiraDx Ltd
15/11/202201:44PR Newswire (US)LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c TestNASDAQ:LMDXLumiraDx Ltd
15/11/202201:41PR Newswire (US)LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c TestNASDAQ:LMDXLumiraDx Ltd
15/11/202201:41PR Newswire (Canada)LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c TestNASDAQ:LMDXLumiraDx Ltd
14/11/202218:58GlobeNewswire Inc.LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c TestNASDAQ:LMDXLumiraDx Ltd
14/11/202215:05TipRanksLumiraDx (LMDX) Gets a Buy from BTIGNASDAQ:LMDXLumiraDx Ltd
 Showing the most relevant articles for your search:NASDAQ:LMDX